Social sustainability

Helping millions of people

We provide accessible, personalised care for people living with intimate healthcare needs. We do this by creating new, innovative products and by making it easier for people to get the care they need.

This supports the UN Sustainable Development Goal 3, which focuses on ensuring healthy lives and promoting people’s wellbeing at every age.

While continuing to make life easier for millions of people around the world, we aim high to balance the wellbeing of users with the planet.

Innovating to improve care

We offer people personalised care by creating new and innovative products, extended solutions and services, that are focused on their needs. Our Clinical Performance Programme aims to bring pioneering, scientifically backed products to market.

Learn more about product sustainability

Helping people access better care

There’s no point creating the right products if people can’t get hold of them. Our long-term ambition is to create access to better care for the next one million new users, across every area of our business and everywhere we operate. 

Our Access to Healthcare programme brings together practitioners, users, NGOs and other public and private stakeholders to empower users, train practitioners and advocate for better care. Since 2007, we’ve supported 100+ projects in 25 countries.

In 2024/25, we supported over two million users across 140 countries and welcomed more than 260,000 new participants to our patient support programmes Coloplast Care and Atos Care.

Diversity, equity and inclusion

We interact with stakeholders, employees, partners, customers, and users with diverse backgrounds across the globe. We want everyone to feel they belong and can fulfil their potential – not despite their differences, but because of them. 

We know diversity drives better results, so we always aim to make sure there’s a healthy balance of genders, ages, and nationalities within each team.

Gender Balance Act

Coloplast A/S is subject to the Danish Gender Balance Act and obliged to disclose information on gender diversity in the Board of Directors and other management levels for employees employed Coloplast A/S.

Members of the Board of Directors: 50% female (3) and 50% male (3).

The Board of Directors comprises six members elected by the shareholders with 50% female and 50% male and three employee elected board members of whichn 100% are male and 0% are female. As Coloplast A/S (Parent Company) does not have an equal gender balance amongst employee elected board members, the election committee has ensured relevant criteria applies in the election process, cf. §7 in the Gender Balance Act. An equal gender balance as of 30 June 2026 has not been reached among employee elected board members as the next employee election to the Board of Directors will take place in November 2026.

Employees in the upper management layers: 39% female (14) and 61% male (22).

The Executive Management registered with the Danish Business Authority comprises the President & CEO and the Executive Vice President, CFO both of whom are males representing a gender balance of 100% male and 0% female.

Coloplast A/S (Parent Company) has defined a target for gender balance in upper management layers aiming for a 40/60% split by 2030. The split of gender balance in upper management layers in Coloplast A/S was 39/61% as of 30 September 2026. During the fiscal year of 2025/26, Coloplast has continued to monitor and ensured gender balance in senior leadership hirings and promotions, and remains committed to achieving the 2030 target.

Workplace safety

We never compromise on safety for our users and in the same way, providing a safe and healthy working environment for our colleagues is a top priority for us.

We strive to nurture a strong safety mindset and reduce work-related injuries for all our employees – whether they work with heavy machinery in manufacturing, operate trucks at our distribution centres, move between sales offices or travel to visit customers.